financetom
Business
financetom
/
Business
/
Rahul Bhatia may back Gangwal on IndiGo exit norm relaxation, says report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rahul Bhatia may back Gangwal on IndiGo exit norm relaxation, says report
Jan 27, 2020 5:20 AM

Rahul Bhatia-owned InterGlobe Enterprises (IGE) is likely to support the proposed resolution by co-promoter Rakesh Gangwal seeking exit norm relaxation, reported Business Standard.

The proposed resolution seeks relaxation of rules on the sale and purchase of shares by its main shareholders, making it easier for the promoters to raise or cut stake in the company, said the report. But for any such resolution to pass 75 percent of shareholder support is required, the report added.

Support from Bhatia, who owns around 38 percent in the company is crucial when the proposal will be discussed during the extraordinary general meeting (EGM) on IndiGo on January 29, the report said.

“It is a good sign for investors. The resolution having the IGE group’s support means that the promoters have mutually discussed the issue and Bhatia is willing to give an opportunity to Gangwal for cashing out. Considering that there is little chance of a hostile takeover, it is a positive move,” Sriram Subramaniam, head of InGovern, a shareholder advisory firm was quoted as saying in the report.

Though Gangwal has openly stated in the past that he will not dilute stake in the firm, he has involvement in the company has decreased considerably since the beginning of his feud with Bhatia, the report said. This was further evident after many old parties seen close to Bhatia were re-appointed in key posts of the firm, the report said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
BRIEF-Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Nov 4, 2025
Nov 4 (Reuters) - Evoke Pharma Inc ( EVOK ): * EVOKE PHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY QOL MEDICAL * EVOKE PHARMA INC ( EVOK ): PROPOSED DEAL FOR FOR $11.00 PER SHARE IN CASH AT CLOSING Source text: Further company coverage: ...
Hillman Q3 net sales rise 8%, beat estimates
Hillman Q3 net sales rise 8%, beat estimates
Nov 4, 2025
Overview * Hillman Q3 2025 net sales rise 8% to record $424.9 mln, beating analyst expectations * Adjusted EPS for Q3 2025 beats consensus, reaching $0.22 per share * Company repurchased 325.6 thousand shares, totaling $3.2 mln Outlook * Hillman maintains FY 2025 net sales guidance at $1.535 to $1.575 bln * Company raises FY 2025 adjusted EBITDA guidance to...
Wingstop Q3 system-wide sales rise 10%, helped by new restaurants
Wingstop Q3 system-wide sales rise 10%, helped by new restaurants
Nov 4, 2025
Overview * Wingstop ( WING ) fiscal Q3 system-wide sales rise 10% to $1.4 bln * Adjusted EBITDA for fiscal Q3 grows 18.6% to $63.7 mln, highest quarter on record * Company opened 114 net new restaurants, achieving 19.3% net new unit growth Outlook * Wingstop ( WING ) revises 2025 domestic same store sales growth to decline 3%-4% *...
Nuvectis Pharma Q3 net loss widens
Nuvectis Pharma Q3 net loss widens
Nov 4, 2025
Overview * Nuvectis Q3 net loss widens to $7.5 mln, driven by milestone and study costs * Cash position improves to $35.4 mln, supported by public offering and ATM facility * NXP900 Phase 1b program initiated, showcasing therapeutic potential in advanced cancers Outlook * Cash runway expected to support operations into 3Q-2027 Result Drivers * Research and development expenses were...
Copyright 2023-2026 - www.financetom.com All Rights Reserved